CYTENA
Thomas Kretschmann began their work experience as an Application Specialist at STRATEC Molecular GmbH in September 2005. Thomas held this position until December 2008. In January 2009, they joined QIAGEN as a Senior Application Specialist and remained with the company until March 2017. In April 2017, Thomas Kretschmann joined CYTENA as a Field Application Specialist, and they were subsequently promoted to Senior Field Application Specialist in April 2019. Their most recent role at CYTENA is L3 Service & Support Coordinator, which they began in October 2021.
Thomas Kretschmann obtained their education in the field of Biochemistry from Universität Greifswald in Germany. Thomas attended the university from 1998 to 2003, earning their Diplom degree.
CYTENA
cytena GmbH has developed a device called cy-Clone to separate single cells. Single cells are required for the development of state-of-the-art drugs, so-called biologicals as well as for the genetic analysis of single cells for cancer and stem cell research. The cy-Clone is supported by an automated imaging process to encapsulate cells indroplets, which are delivered to any type of substrate. Thanks to this particularly gentle delivery method, the cells are able to survive post printing and can either be analyzed thereafter or grown into clonal colonies. To determine clonality, multiple images are recorded during the process. Cross-contamination is avoided by the use of disposable parts.